Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ioannides

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
The Science of the Total Environment|August 15, 1993
Transport of radiocaesium from a sheep's diet to its tissuesP A Assimakopoulos, K G Ioannides, A A Pakou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1993
Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptidesC G Ioannides, B Fisk, K R Jerome, et al.
Anticancer Research|August 10, 2002
Helper peptide G89 (HER-2:777-789) and G89-activated cells regulate the survival of effectors induced by the CTL epitope E75 (HER-2, 369-377). Correlation with the IFN-gamma: IL-10 balanceTom V Lee, Dennis A Johnston, Nicholas Thomakos, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibodyC G Ioannides, K Itoh, F E Fox, et al.
Cellular Immunology|October 1, 1993
Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogeneC G Ioannides, B Fisk, D Fan, et al.
Scandinavian Journal of Immunology|December 1, 1994
Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL linesB Fisk, C N Flytzanis, M S Pollack, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 1999
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cellsL D Anderson, J M Hudson, C A Savary, et al.
Cancer Research|August 15, 1991
Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascitesC G Ioannides, C D Platsoucas, S Rashed, et al.
Annals of Surgical Oncology|December 30, 1998
Ovarian cancer-associated lymphocyte recognition of folate binding protein peptidesG E Peoples, B W Anderson, B Fisk, et al.
In Vivo (Athens, Greece)|January 1, 1991
Immunological effects of tumor vaccines: III. Influenza virus oncolysates inhibit the TPA induced activation of peripheral blood mononuclear cellsC G Ioannides, R S Freedman, R Patenia, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
The Science of the Total Environment|August 15, 1993
Transport of radiocaesium from a sheep's diet to its tissuesP A Assimakopoulos, K G Ioannides, A A Pakou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1993
Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptidesC G Ioannides, B Fisk, K R Jerome, et al.
Anticancer Research|August 10, 2002
Helper peptide G89 (HER-2:777-789) and G89-activated cells regulate the survival of effectors induced by the CTL epitope E75 (HER-2, 369-377). Correlation with the IFN-gamma: IL-10 balanceTom V Lee, Dennis A Johnston, Nicholas Thomakos, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Identification of a second T-cell antigen receptor in human and mouse by an anti-peptide gamma-chain-specific monoclonal antibodyC G Ioannides, K Itoh, F E Fox, et al.
Cellular Immunology|October 1, 1993
Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogeneC G Ioannides, B Fisk, D Fan, et al.
Scandinavian Journal of Immunology|December 1, 1994
Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL linesB Fisk, C N Flytzanis, M S Pollack, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 1999
HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cellsL D Anderson, J M Hudson, C A Savary, et al.
Cancer Research|August 15, 1991
Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascitesC G Ioannides, C D Platsoucas, S Rashed, et al.
Annals of Surgical Oncology|December 30, 1998
Ovarian cancer-associated lymphocyte recognition of folate binding protein peptidesG E Peoples, B W Anderson, B Fisk, et al.
In Vivo (Athens, Greece)|January 1, 1991
Immunological effects of tumor vaccines: III. Influenza virus oncolysates inhibit the TPA induced activation of peripheral blood mononuclear cellsC G Ioannides, R S Freedman, R Patenia, et al.
Pageof 14